Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.
Follow-Up Questions
What is Alpha Tau Medical Ltd (DRTS)'s P/E Ratio?
The P/E ratio of Alpha Tau Medical Ltd is N/A
Who is the CEO of Alpha Tau Medical Ltd?
Mr. Uzi Sofer is the Chairman of the Board of Alpha Tau Medical Ltd, joining the firm since 2015.
What is the price performance of DRTS stock?
The current price of DRTS is 0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Alpha Tau Medical Ltd?
Alpha Tau Medical Ltd belongs to Health Care industry and the sector is Health Care
What is Alpha Tau Medical Ltd market cap?
Alpha Tau Medical Ltd's current market cap is $0
Is Alpha Tau Medical Ltd a buy, sell, or hold?
According to wall street analysts, 6 analysts have made analyst ratings for Alpha Tau Medical Ltd, including 4 strong buy, 5 buy, 1 hold, 0 sell, and 4 strong sell
